Cited by 24Voice and Speech DisordersPhonetics and Phonology ResearchParkinson's Disease Mechanisms and Treatments

The effect of increased vocal intensity on interarticulator timing in speakers with Parkinson's disease: A preliminary analysis

Open access
Richardson, Kelly, Sussman, Joan E., Stathopoulos, Elaine T., Huber, Jessica E.·2014·Journal of Communication Disorders

Abstract

Purpose The purpose of the current study was to investigate the effect of increased vocal intensity on interarticulator timing in individuals with Parkinson's disease (PD). Methods Ten individuals with mild to moderate hypophonia, secondary to PD, were selected for study. Over an 8-week treatment period, multi-talker babble noise was presented monaurally to the individuals with PD during everyday communication contexts to elicit increased vocal intensity (Lombard effect). Outcome measures included sound pressure level (SPL), voice onset time (VOT), VOT ratio, percent voicing, and speech intelligibility. Results Group and individual participant responses to the treatment are reported and discussed. Speakers with PD were shown to significantly increase SPL in response to treatment. Six of the 10 speakers showed improved temporal coordination between the laryngeal and supralaryngeal mechanisms (interarticulator timing) in response to treatment. Four of the 10 speakers, however, showed reduced laryngeal–supralaryngeal timing at the end of treatment. Group speech intelligibility scores were significantly higher post-treatment as compared to pre-treatment. Conclusions Voice treatment during everyday communication resulted in improved temporal coordination across the laryngeal and supralaryngeal mechanisms for the majority of speakers with PD and made them easier to understand. Further investigations are planned to explore individual differences in response to treatment. The identification of speaker-specific voicing and devoicing strategies is consistent with the heterogeneous nature of PD. Learning outcomes Readers will be able to: 1. Describe the speech and voice characteristics of individuals with Parkinson's disease. 2. Define the Lombard effect. 3. Describe acoustic measures of voice onset time and percent voicing. 4. Describe the effect of voice treatment on voice onset time and percent voicing in individuals with Parkinson's disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcomdis.2014.09.004

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The present SPL data are consistent with prior studies reporting vocal intensity gains in monologue speech after completing LSVT LOUD therapy and when using the SpeechVive prosthetic.

    “The present SPL data are consistent with prior studies reporting vocal intensity gains in monologue speech after completing the LSVT LOUD therapy (Ramig et al., 2018; Ramig, Sapir, Countryman, et al., 2001) and when using the SpeechVive prosthetic (Richardson et al., 2014; Stathopoulos et al., 2014).”

    From Perception of Physical Demand, Mental Demand, and Performance: A Comparison of Two Voice Interventions for Parkinson's Disease (2022) · cites this paper as Richardson et al., 2014

    The Results (§3.1.3; page unavailable) report a significant 2.9 dB SPL increase after SpeechVive treatment, and the device-setting passage (§2.2.2) describes increased intensity during conversational speech while wearing it. But the measured treatment outcome came from reading short sentences without the device, not monologue speech while using SpeechVive (§§2.3.1–2.3.2). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • The present SPL data are consistent with prior studies reporting vocal intensity gains in monologue speech after completing LSVT LOUD therapy or while wearing the SpeechVive prosthesis.

    “The present SPL data are consistent with prior studies reporting vocal intensity gains in monologue speech after completing LSVT LOUD therapy (Ramig et al., 2018; Ramig, Sapir, Countryman, et al., 2001; Ramig, Sapir, Fox, & Countryman, 2001) or while wearing the SpeechVive prosthesis (Richardson et al., 2014; Stathopoulos et al., 2014).”

    From Respiratory Responses to Two Voice Interventions for Parkinson's Disease (2022) · cites this paper as Richardson et al., 2014

    The Device setting section reports that participants spoke approximately 3 dB louder during conversational speech while wearing SpeechVive. But the measured treatment gains came from reading short sentences, not monologue speech, and the Treatment paradigm says participants did not wear the device during testing. The paper therefore supports an intensity gain associated with SpeechVive, but not the specified monologue result. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Prior studies have demonstrated a positive Lombard effect in individuals with PD.

    “Prior studies have demonstrated a positive Lombard effect in individuals with PD (Adams et al., 2020; Richardson et al., 2014; Shrivastav et al., 2014; Stathopoulos et al., 2014).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 108 · Cited by 24

Research works printed but not linked: 80

  1. Ackermann H Ziegler W 1991 Articulatory deficits in parkinsonian dysarthria: an acoustic analysis Journal of Neurology, Neurosurgery, and Psychiatry 54 12 1093 1098 PMC1014687 1783924
  2. Adams S Moon BH Dykstra A Abrams K Jenkins M Jog M 2006 Effects of multitalker noise on conversational speech intensity in Parkinson’s disease Journal of Medical Speech–Language Pathology 14 4 221 228
  3. Adams S Lang AE 1992 Can the Lombard effect be used to improve low voice intensity in Parkinson’s disease? European Journal of Disorders of Communication 27 2 121 127 1446099
  4. Baumgartner C Sapir S Ramig LO 2001 Perceptual voice quality changes following phonatory-respiratory effort treatment (LSVT®) vs respiratory effort treatment for individuals with Parkinson disease Journal of Voice 15 105 114 12269625
  5. Brodal P 1998 The central nervous system: structure and function 2 New York Oxford University Press
  6. Cannito MP Burch AR Watts C Rappold PW Hood SB Sherrard K 1997 Disfluency in spasmodic dysphonia: a multivariate analysis Journal of Speech, Language, and Hearing Research 40 3 627 641 9210119
  7. Canter GJ 1963 Speech characteristics of patients with Parkinson’s disease: I. Intensity, pitch, and duration The Journal of Speech and Hearing Disorders 28 221 229 14048984
  8. Canter GJ 1965 Speech characteristics of patients with Parkinson’s disease: I. Intensity, pitch, and duration: articulation, diadochokinesis, and overall speech adequacy The Journal of Speech and Hearing Disorders 30 217 224 14321495
  9. Darley FL Aronson AE Brown JR 1969 Clusters of deviant speech dimensions in the dysarthrias Journal of Speech and Hearing Research 12 3 462 496 5811846
  10. Darley FL Aronson AE Brown JR 1975 Motor Speech Disorders Philadelphia W.B. Saunders
  11. Darling M Huber JE 2011 Changes to articulatory kinematics in response to loudness cues in individuals with Parkinson’s disease Journal of Speech-Language and Hearing Research 54 5 1247 1259 PMC3433496 21386044
  12. Dewar A Dewar AD Austin WTS Brash HM 1979 The long term use of an automatically triggered auditory feedback masking device in the treatment of stammering British Journal of Disorders of Communication 14 3 219 229
  13. Dromey C Ramig LO Johnson AB 1995 Phonatory and articulatory changes associated with increased vocal intensity in Parkinson’s disease: A case study Journal of Speech and Hearing Research 38 4 751 764 7474969
  14. Dromey C Ramig LO 1998a The effect of lung volume on selected phonatory and articulatory variables Journal of Speech, Language & Hearing Research 41 3 491 9638915
  15. Dromey C Ramig LO 1998b Intentional changes in sound pressure level and rate: Their impact on measures of respiration Journal of Speech, Language & Hearing Research 41 5 1003 1018 9771624
  16. Doyle P Raade A St Pierre A Desai S 1995 Fundamental frequency and acoustic variability associated with production of sustained vowels by speakers with hypokinetic dysarthria Journal of Medical Speech–Language Pathology 3 41 50
  17. Duffy JR 2005 Motor speech disorders: Substrates, differential diagnosis, and management 2 St. Louis Mosby
  18. Fischer E Goberman AM 2010 Voice onset time in Parkinson disease Journal of Communication Disorders 43 21 34 19717164
  19. Flint AJ Black SE Campbell-Taylor I Gailey GF Levinton C 1992 Acoustic analysis in the differentiation of Parkinson’s disease and major depression Journal of Psycholinguistic Research 21 5 383 389 1447729
  20. Folkins JW Dromey C Zimmermann GN 1982 Lip and jaw interaction during speech: Response to perturbation of lower-lip movement prior to bilabial closure Journal of the Acoustical Society of America 71 1225 1233 7085994
  21. Forrest K Weismer G Turner GS 1989 Kinematic, acoustic, and perceptual analyses of connected speech produced by parkinsonian and normal geriatric adults The Journal of The Acoustical Society of America 85 6 2608 2622 2745883
  22. Forrest K Weismer G 1997 Acoustic analysis of dysarthric speech McNeil MR Clinical Management of Sensorimotor Speech Disorders 63 80 New York Thieme
  23. Fox C Morrison CE Ramig LO Sapir S 2002 Current perspectives on the Lee Silverman Voice Treatment (LSVT®) for individuals with idiopathic Parkinson disease American Journal of Speech-Language Pathology 11 111 123
  24. Frisch SA Wright R 2002 The phonetics of phonological speech errors: An acoustic analysis of slips of the tongue Journal of Phonetics 30 139 162
  25. Gallena S Smith PJ Zeffiro T Ludlow CL 2001 Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease Journal of Speech, Language, and Hearing Research 44 6 1284 1299 11776365
  26. Geumann A 2001 Vocal intensity: acoustic and articulatory correlates Proceedings from the 4th Conference on Motor Control Nijmegen, Nethelands
  27. Goberman AM Coelho C Robb M 2005 Prosodic characteristics of Parkinsonian speech: the effect of levodopa-based medications Journal of Medical Speech–Language Pathology 13 51 68
  28. Goberman AM Blomgren M 2008 Fundamental frequency change during offset and onset of voicing in individuals with Parkinson disease Journal of Voice 22 2 178 191 16950600
  29. Gonyea WJ 1980 Role of exercise in inducing increases in skeletal muscle fiber number Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology 48 3 421 426 7372511
  30. Gonyea WJ Sale D 1982 Physiology of weight-lifting exercise Archives of Physical Medicine and Rehabilitation 63 5 235 237 7073463
  31. Hanson DG Gerratt BR Ward PH 1984 Cinegraphic observations of laryngeal function in Parkinson’s disease The Laryngoscope 94 3 348 353 6700351
  32. Hertrich I Ackermann H 1995 Gender-specific vocal dysfunctions in Parkinson’s disease: electroglottographic and acoustic analyses The Annals of Otology, Rhinology, and Laryngology 104 3 197 202 7872602
  33. Ho AK Bradshaw JL Iansek T 2000 Volume perception in parkinsonian speech Movement Disorders 15 6 1125 1131 11104195
  34. Hoehn M Yahr M 1967 Parkinsonism: onset, progression and mortality Neurology 17 5 427 442 6067254
  35. Huber JE Darling M 2011 Effect of Parkinson’s disease on the production of structured and unstructured speaking tasks: Respiratory physiologic and linguistic considerations Journal of Speech, Language and Hearing Research 54 1 33 46 PMC3454440 20844256
  36. Huber JE Stathopoulos ET Curione GM Ash TA Johnson K 1999 Formants of children, women and men: The effects of vocal intensity variation Journal of Acoustical Society of America 106 1532 1542 10489709
  37. Huber JE Stathopoulos ET Ramig LO Lancaster SL 2003 Respiratory function and variability in individuals with Parkinson disease: pre- and post-Lee Silverman Voice Treatment Journal of Medical Speech–Language Pathology 11 4 185 202
  38. Isshiki N 1964 Regulatory mechanism of voice intensity variation Journal of Speech and Hearing Research 7 17 29 14130741
  39. Jessen M 2002 An acoustic study of contrasting plosives and click accompaniments in Xhosa Phonetica 59 150 179 12232465
  40. Kent RD Kent JF Duffy JR Weismer G 1998 The dysarthrias: Speech-voice profiles, related dysfunctions, and neuropathology Journal of Medical Speech–Language Pathology 6 4 165 211
  41. Kent RD Rosenbeck JC 2004 Prosodic disturbance and neurologic lesion Brain and Language 15 2 259 291 7074345
  42. Klatt DH 1975 Voice onset time, frication, and aspiration in word-initial consonants clusters Journal of Speech and Hearing Research 18 686 706 1207100
  43. Lane H Tranel B 1971 The Lombard sign and the role of hearing in speech Journal of Speech and Hearing Research 14 677 709
  44. Lang AE Lozano AM 1998 Parkinson’s disease. First of two parts The New England Journal of Medicine 339 15 1044 1053 9761807
  45. Lisker L 1986 “Voicing” in English: A catalogue of acoustic features signaling /b/ versus /p/ in trochees Language and Speech 29 1 3 11 3657346
  46. Lofqvist A Yoshioka H 1981 Interarticulator programming in obstruent production Phonetica 38 21 34 7267720
  47. Logemann JA Fisher HB 1981 Vocal tract control in Parkinson’s disease: phonetic feature analysis of misarticulations Journal of Speech and Hearing Disorders 46 4 348 352 7300262
  48. Ludlow CL Yeh J Cohen LG Van Pelt F Rhew K Hallett M 1994 Limitations of laryngeal electromyography and magnetic stimulation for assessing laryngeal muscle control Annals of Otology, Rhinology, and Laryngology 103 16 27 8291855
  49. Lyle S 2008 Dialect Variation in Stop Consonant Voicing A dissertation thesis The Ohio State University
  50. Mangan K 1961 Speech improvement through articulation testing American Annals of the Deaf 106 391 396
  51. Markides A 1970 The speech of deaf and partially hearing children with special reference to factors affecting intelligibility British Journal of Disorders of Communication 2 126 140 5495165
  52. Millin J 1971 Therapy for reduction of continuous phonation in the hard-of hearing population Journal of Speech and Hearing Disorders 36 496 498 5125802
  53. Monsen RB 1976 A production of English stop consonants in the speech of deaf children Journal of Phonetics 4 29 42
  54. Nober H 1967 Articulation of the deaf Exceptional Children 33 611 621 6042707
  55. Perez KS Ramig LO Smith ME Dromey C 1996 The Parkinson larynx: tremor and videostroboscopic findings Journal of Voice 10 4 354 361 8943139
  56. Ramig LO Countryman S O’Brien C Hoehn M Thompson L 1996 Intensive speech treatment for patients with Parkinson’s disease: short- and long-term comparison of two techniques American Academy of Neurology 47 1496 1504 8960734
  57. Ramig LO Countryman S Thompson L Horii Y 1995 Comparison of two forms of intensive speech treatment for Parkinson disease Journal of Speech and Hearing Research 38 6 1232 1251 8747817
  58. Ramig LO Fox C Sapir S 2008 Speech treatment for Parkinson’s disease Expert Review of Neurotherapeutics 8 2 297 309 18271714
  59. Ramig LO Sapir S 2001 Intensive voice treatment (LSVT®) for patients with Parkinson’s disease: a 2 year follow up Journal of Neurology 71 493 498 PMC1763504 11561033
  60. Ravizza SM 2003 Dissociating the performance of cortical and subcortical patients on phonemic tasks Brain and Cognition 53 2 301 310 14607169
  61. Repp BH 1983 Trading relations among acoustic cues Proceedings from the Tenth International Congress of Phonetic Sciences Utrecht, Netherlands
  62. Sapir S Spielman JL Ramig LO Story BH Fox C 2007 Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT®]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: Acoustic and perceptual findings Journal of Speech, Language & Hearing Research 50 4 899 17675595
  63. Shrivastav R Skowronski MD Kopf LM Rakerd B 2014 Acoustic characteristics of the Lombard effect from talkers with Parkinson’s disease Journal of the Acoustical Society of America 135 4 2426
  64. Smith CR 1975 Residual hearing and speech production in deaf children Journal of Speech and Hearing Research 18 795 811 1207108
  65. Smith BL 1979 A phonetic analysis of consonantal devoicing in children’s speech Journal of Child Language 6 19 28
  66. Smith ME Ramig LO Dromey C Perez KS Samandari R 1995 Intensive voice treatment in Parkinson disease: laryngostroboscopic findings Journal of Voice 9 4 453 459 8574314
  67. Solomon NP Hixon TJ 1993 Speech breathing in Parkinson’s disease Journal of Speech and Hearing Research 36 2 294 310 8487522
  68. Spielman J Ramig LO Story B Fox C 2000 Expansion of vowel space in Parkinson’s disease following LSVT® Proceedings from the American Speech-Language-Hearing Association annual convention Washington, DC
  69. Stathopoulos ET Weismer G 1983 Closure duration of stop consonants Journal of Phonetics 11 395 400
  70. Sweeting PM Baken RJ 1982 Voice onset time in normal-aged population Journal of Speech and Hearing Research 25 1 129 134 7087415
  71. Tjaden K Wilding G 2004 Rate and loudness manipulations in dysarthria: Acoustic and perceptual findings Journal of Speech, Language, and Hearing Research 47 766 783 15324285
  72. Tom K Titze IR Hoffman EA Story BH 2001 Three-dimensional vocal tract imaging and formant structure: Varying vocal register, pitch, and loudness The Journal of Acoustical Society of America 109 2 742 747 11248978
  73. Tukey JW 1970 Exploratory data analysis Reading, PA Addison-Wesley
  74. Turner GS Weismer G 1993 Characteristics of speaking rate in the dysarthria associated with amyotrophic lateral sclerosis Journal of Speech and Hearing Research 36 1134 1144 8114480
  75. Van Lieshout PHHM Peters HFM Bakker AJ 1997 En route to a speech motor test: A first halt Hulstijn W Peters HFM van Lieshout PHHM Speech Production: Motor Control, Brain Research and Fluency Disorders 463 471 Amsterdam Elsevier
  76. Volkow ND Gur RC Wang GJ Fowler JS Moberg PJ Ding YS Logan J 1998 Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals The American Journal of Psychiatry 155 3 344 349 9501743
  77. Wang YT Kent RD Duffy JR Thomas JE Weismer G 2004 Alternating motion rate as an index of speech motor disorder in traumatic brain injury Clinical Linguistics & Phonetics 18 1 57 84 15053268
  78. Watson BC 1998 Fundamental frequency during phonetically governed devoicing in normal young and aged speakers The Journal of The Acoustical Society of America 103 6 3642 3647 9637045
  79. Winer BJ 1962 Statistical Principles in Experimental Design Multifactor Experiments Having Repeated Measures on the Same Elements 298 378 New York McGraw-Hill
  80. Zgaljardic DJ Borod JC Foldi NS Mattis P 2003 A review of the cognitive and behavioral sequelae of Parkinson’s disease: relationship to frontostriatal circuitry Cognitive and Behavioral Neurology 16 4 193 210 14665819

Authors
Richardson, K., Sussman, J. E., Stathopoulos, E. T., & Huber, J. E.
Affiliations
  • University at Buffalo, State University of New York (US)
  • Purdue University West Lafayette (US)
Corresponding author
Richardson, Kelly
Venue
Journal of Communication Disorders
Publisher
Elsevier BV
Published
2014-11
Volume
52
Pages
44-64
ISSN
0021-9924 (ISSN-L)
OpenAlex
W2090001111
Cited by
24
References
108
Citations by year
2026: 4 · 2024: 3 · 2023: 1 · 2022: 6 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 1
FWCI
0.67
Type
journal article
Language
en
Open access
Locations
  • Journal of Communication Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health
  • National Institute on Deafness and Other Communication Disorders
  • Indiana Clinical and Translational Sciences Institute (TR000006)
Topics
  • Health Sciences › Medicine › Physiology › Voice and Speech Disorders
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Phonetics and Phonology Research
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
Keywords
Parkinson's disease, hypophonia, Lombard effect, vocal intensity, voice onset time, speech intelligibility, sound pressure level, voice therapy
MeSH terms
Aged, Cues, Female, Humans, Male, Parkinson Disease, Speech, Speech Acoustics, Speech Disorders, Speech Intelligibility, Time Factors, Voice, Voice Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review